C-Bridge closes $400M Chinese fund

C-Bridge Capital has closed its second fund at $400 million, exceeding its $300 million target. The firm will invest about half of the fund in Chinese pharma and biotech companies, including developers of candidates in-licensed from U.S. and European sources. The balance will go to Chinese medical device and service companies...